U.S. Food and Drug Administration Center for Drug Evaluation and ResearchSkip navigation

CDER - Center for Drug Evaluation and Research Logo

Drug Information

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

Approvals - September 2002

ANDA Number Generic Drug Name Applicant Approval Date
1 65-058 CEFACLOR EXTENDED-RELEASE TABLETS, USP 375 MG 500 MG TEVA PHARMACEUTICALS USA 9/4/02
2 75-163 TIMOLOL MALEATE OPHTHALMIC SOLUTION, USP 0.5% (BASE) HI-TECH PHARMACAL CO., INC. 9/10/02
3 75-893 FLUVOXAMINE MALEATE TABLETS 25 MG 50 MG 100 MG TEVA PHARMACEUTICALS USA 9/10/02
4 76-350 POTASSIUM IODIDE TABLETS, USP 65 MG RECIP, AB 9/10/02
5 75-819 AMANTADINE HYDROCHLORIDE SYRUP, USP 50 MG/5 ML CAROLINA MEDICAL PRODUCTS COMPANY, INC. 9/11/02
6 75-668 NIZATIDINE CAPSULES, USP 150 MG AND 300 MG TEVA PHARMACEUTICALS USA 9/12/02
7 65-102 AMOXICILLIN AND CLAVULANATE POTASSIUM TABLETS, USP 875 MG AND 125 MG (BASE), RESPECTIVELY RANBAXY LABORATORIES, LTD. 9/17/02
8 75-907 HYDROCHLOROTHIAZIDE CAPSULES 12.5 MG VINTAGE PHARMACEUTICALS, INC. 9/17/02
9 75-804 NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS 0.25 MG/0.035 MG, RESPECTIVELY, 28-DAY REGIMEN. BARR LABORATORIES, INC. 9/25/02
10 75-519 RANITIDINE TABLETS, USP (OTC) 75 MG GENEVA PHARMACEUTICALS, INC. 9/26/02
11 75-526 TICLOPIDINE HYDROCHLORIDE TABLETS 250 MG CARACO PHARMACEUTICAL LABORATORIES, LTD. 9/26/02
12 76-130 ALBUTEROL EXTENDED-RELEASE TABLETS 4 MG AND 8 MG SIDMAK LABORATORIES, INC. 9/26/02
13 76-140 SOTALOL HYDROCHLORIDE TABLETS 80 MG, 120 MG, 160 MG, AND 240 MG TORPHARM 9/26/02
14 40-470 AMPHETAMINE AND DEXTROAMPHETAMINE (MIXED SALTS) TABLETS 5 MG (TOTAL) EON LABS, INC. 9/27/02
15 76-102 LISINOPRIL TABLETS, USP 2.5 MG, 5 MG, 10 MG, 20 MG, 30 MG, AND 40 MG    

totop.gif (1525 bytes) Back to Top   Back Back to Approvals

FDA/Center for Drug Evaluation and Research
Last Updated: October 15, 2002
Originator: OTCOM/OGD
HTML by SJW